MENU
BIIB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Biogen (BIIB) Ownership - Who owns Biogen?
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
19.16B
P/E Ratio
12.50
Total Cash
2.76B
Projected Growth
4.71
Total Debt
6.59B
Revenue
10B
Risk (Beta)
-0.07
Dividend Yield
N/A
Total Cash/Share
18.82
Total Debt/Equity
6.50
Revenue/Share
68.33 USD as % of share price
Fundamentals
BIIB
Capitalization
19.2B
P/E Ratio
12.50
Risk (Beta)
-0.07
Dividend Yield
N/A
Total Cash
2.76B
Total Cash/Share
18.82
Total Debt
6.6B
Total Debt/Equity
6.50
Projected Growth (PEG Ratio)
4.71
Revenue/Share (as % of the share price)
68.33%
Revenue
10B
ROE
N/A
Book Value
17.6B
P/B Ratio
1.09
Cash Flow
N/A
Earnings
10.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
2.50
Current Revenue Per Employee
347863.25
Dividends Per Share - Security
N/A
EBITDA
2.79B
Float
N/A
Float - Current
N/A
Gross Income Margin
77.13
Revenue To Assets
5.55
Shares Held By Institutions
58.9B
Shares Outstanding - Current
147M
Total Liabilities
10.7B
Total Volume MTD
N/A
Value
-1
Gain YTD
-16.460
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BIIB showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com